ý
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
|
o
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
|
Delaware
|
59-3134518
|
|
(State
or other jurisdiction of
|
(I.R.S.Employer
|
|
incorporation
or organization)
|
Identification
Number)
|
|
Page
|
|
PART
I – FINANCIAL INFORMATION
|
||
Item
1
|
Financial
Statements
|
4
|
Item
2
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
17
|
Item
4
|
Controls
and Procedures
|
23
|
PART II – OTHER INFORMATION
|
|
|
Item
1
|
Legal
Proceedings
|
24
|
Item
1A
|
Risk
Factors
|
24
|
Item
2
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
24
|
Item
3
|
Defaults
Upon Senior Securities
|
24
|
Item
4
|
Submission
of Matters to a Vote of Security Holders
|
24
|
Item
5
|
Other
Information
|
24
|
Item
6
|
Exhibits
|
24
|
Signatures
|
25
|
March 31,
|
December 31,
|
|||||||
2009
|
2008
|
|||||||
ASSETS
|
(unaudited)
|
*
|
||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 207 | $ | 405 | ||||
Trade
receivables
|
1,249 | 1,366 | ||||||
Inventories,
net
|
1,346 | 1,353 | ||||||
Prepaid
expenses and other current assets
|
137 | 99 | ||||||
Total
current assets
|
2,939 | 3,223 | ||||||
Fixed
assets, net
|
95 | 98 | ||||||
Total
assets
|
$ | 3,034 | $ | 3,321 | ||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
||||||||
Current
liabilities:
|
||||||||
Line
of credit
|
$ | 349 | $ | - | ||||
Trade
payables to related parties
|
241 | 393 | ||||||
Trade
payables and other accrued expenses
|
390 | 398 | ||||||
Income
taxes payable
|
- | 75 | ||||||
Deferred
revenue and customer deposits
|
138 | 187 | ||||||
Fair
value of warrant liability
|
350 | 350 | ||||||
Total
current liabilities
|
1,468 | 1,403 | ||||||
Liability
under derivative contracts
|
8 | 9 | ||||||
Total
liabilities
|
1,476 | 1,412 | ||||||
Commitments
and contingencies (Note 11)
|
||||||||
Convertible
preferred stock:
|
||||||||
Series
B convertible preferred stock, $.001 par value, 2,000 authorized, 1.5
shares issued and outstanding at March 31, 2009 and December 31, 2008;
liquidation value of $150 at March 31, 2009 and December 31,
2008
|
132 | 120 | ||||||
Stockholders’
equity:
|
||||||||
Common
stock $.001par value, 50,000 authorized, 18,469 and 18,444 shares issued
and outstanding at March 31, 2009 and December 31, 2008,
respectively
|
18 | 18 | ||||||
Additional
paid-in capital
|
34,893 | 34,602 | ||||||
Accumulated
deficit
|
(33,485 | ) | (32,831 | ) | ||||
Total
stockholders’ equity
|
1,426 | 1,789 | ||||||
Total
liabilities and stockholders’ equity
|
$ | 3,034 | $ | 3,321 |
Three Months Ended March 31,
|
||||||||
2009
|
2008
|
|||||||
Net
sales
|
$ | 2,015 | $ | 2,538 | ||||
Cost
of sales
|
1,237 | 1,805 | ||||||
Gross
profit
|
778 | 733 | ||||||
Operating
expenses:
|
||||||||
Selling,
general and administrative
|
1,189 | 961 | ||||||
Research
and development
|
231 | 203 | ||||||
Total
operating expenses
|
1,420 | 1,164 | ||||||
Operating
loss
|
(642 | ) | (431 | ) | ||||
Total
other income (expense)
|
- | (47 | ) | |||||
Net
loss before income taxes
|
(642 | ) | (478 | ) | ||||
Provision
for income taxes
|
- | 2 | ||||||
Net
loss
|
(642 | ) | (480 | ) | ||||
Accretion
of preferred stock redemption value
|
(12 | ) | (89 | ) | ||||
Preferred
stock dividends
|
- | (13 | ) | |||||
Deemed
dividend on preferred stock
|
- | (231 | ) | |||||
Net
loss available to common stockholders
|
$ | (654 | ) | $ | (813 | ) | ||
Net
loss available to common stockholders per common share – basic and
diluted
|
$ | (0.04 | ) | $ | (0.05 | ) | ||
Weighted
average common shares outstanding:
|
||||||||
Basic
and diluted
|
18,463 | 16,442 |
Three Months Ended
March 31,
|
||||||||
2009
|
2008
|
|||||||
Operating
activities:
|
||||||||
Net
loss
|
$ | (642 | ) | $ | (480 | ) | ||
Adjustments
to reconcile net loss to net cash provided (used) by operating
activities:
|
||||||||
Depreciation
expense
|
10 | 16 | ||||||
Stock-based
compensation cost – options
|
180 | 110 | ||||||
Fair
value of common stock and warrants issued for services
rendered
|
111 | 34 | ||||||
Interest
expense attributable to amortization of debt issuance
costs
|
- | 84 | ||||||
Change
in fair value of derivative instruments
|
(1 | ) | 17 | |||||
Other
non-cash non-operating income/expenses, net
|
- | (104 | ) | |||||
Changes
in operating assets and liabilities:
|
||||||||
Trade
receivables
|
117 | 846 | ||||||
Inventories
|
7 | 206 | ||||||
Prepaid
expenses and other current assets
|
(38 | ) | 3 | |||||
Trade
payables to related parties
|
(152 | ) | 137 | |||||
Trade
payables and other current liabilities
|
(8 | ) | (127 | ) | ||||
Income
taxes payable
|
(75 | ) | - | |||||
Deferred
revenue and customer deposits
|
(49 | ) | - | |||||
Cash
(used) provided by operating activities
|
(540 | ) | 742 | |||||
Investing
activities:
|
||||||||
Cash
proceeds from sale of assets
|
- | 400 | ||||||
Capital
expenditures
|
(7 | ) | - | |||||
Cash
(used) provided by investing activities
|
(7 | ) | 400 | |||||
Financing
activities:
|
||||||||
Net
advances
(payments) on bank line of credit
|
349 | (1,321 | ) | |||||
Payments
on notes payable
|
- | (300 | ) | |||||
Proceeds
from exercise of employee stock options
|
- | 8 | ||||||
Cash
provided (used) by financing activities
|
349 | (1,613 | ) | |||||
Net
decrease in cash and cash equivalents
|
(198 | ) | (471 | ) | ||||
Cash
and cash equivalents at beginning of period
|
405 | 1,770 | ||||||
Cash
and cash equivalents at end of period
|
$ | 207 | $ | 1,299 | ||||
Supplemental
disclosures of cash flow information:
|
||||||||
Cash
paid during the period for:
|
||||||||
Interest
|
$ | 4 | $ | 63 | ||||
Income
taxes
|
$ | 75 | $ | 2 | ||||
Non-cash
investing and financing activities:
|
||||||||
Conversion
of convertible preferred stock to common stock
|
$ | - | $ | 1,341 |
|
·
|
Document
and information management;
|
|
·
|
Identification
card scanners;
|
|
·
|
Passport
security scanners;
|
|
·
|
Bank
note and check verification;
|
|
·
|
Business
card readers;
|
|
·
|
Barcode
scanning; and
|
|
·
|
Optical
mark readers used in lottery
terminals.
|
Three months Ended
March 31,
|
||||||||
2009
|
2008
|
|||||||
Customer
A
|
33 | % | 25 | % | ||||
Customer
B
|
21 | * | ||||||
Customer
C
|
10 | 21 | ||||||
Customer
D
|
10 | * | ||||||
Customer
E
|
* | 28 | ||||||
Customer
F
|
* | 10 |
Option Approval Method
|
Options Outstanding and Options Available
|
|||||||||||||||||||||||
Description
|
Board of
Directors
|
Board of
Directors
and
Shareholders
|
Total
|
Outstanding
|
Available
For
Future
Grant
|
Total
|
||||||||||||||||||
2002
Amended and Restated Stock Option Plan
|
- | 3,200,000 | 3,200,000 | 3,200,000 | - | 3,200,000 | ||||||||||||||||||
Key
Personnel Option Grants
|
6,650,000 | - | 6,650,000 | 4,891,165 | - | 4,891,165 | ||||||||||||||||||
2006
Stock Option Plan
|
2,500,000 | 2,500,000 | 1,454,333 | 1,045,667 | 2,500,000 | |||||||||||||||||||
Total
|
6,650,000 | 5,700,000 | 12,350,000 | 9,545,498 | 1,045,667 | 10,591,165 |
Three Months Ended March
31,
|
||||||||
2009
|
2008
|
|||||||
Selling,
general and administrative
|
$ | 147 | $ | 86 | ||||
Research
and development
|
33 | 24 | ||||||
$ | 180 | $ | 110 |
Options
|
Weighted-
Average
Exercise
Price
|
|||||||
Outstanding
at December 31, 2008
|
9,295,498 | $ | 0.32 | |||||
Granted
|
250,000 | 0.49 | ||||||
Exercised
|
- | - | ||||||
Cancelled
|
- | - | ||||||
Outstanding
at March 31, 2009
|
9,545,498 | $ | 0.32 |
Options Outstanding
|
Options Exercisable
|
|||||||||||||||||||
Range of
Exercise Prices
|
Number
Outstanding
|
Weighted-
Average
Remaining
Contractual
Life (Years)
|
Weighted-
Average
Exercise
Price
|
Number
Exercisable
|
Weighted-
Average
Exercise
Price
|
|||||||||||||||
$0.01
|
2,241,165 | 3.07 | $ | 0.01 | 2,241,165 | $ | 0.01 | |||||||||||||
$0.30
|
5,035,000 | 9.29 | $ | 0.30 | - | - | ||||||||||||||
$0.45 - $0.51
|
250,000 | 6.81 | $ | 0.49 | - | - | ||||||||||||||
$0.60 - $0.70
|
2,019,333 | 9.81 | $ | 0.69 | 2,019,333 | $ | 0.69 | |||||||||||||
9,545,498 | 4,260,498 |
March 31,
2009
|
December 31,
2008
|
|||||||
Series
B Stock remaining contractual term (years)
|
0.35 | 0.6 | ||||||
Expected
volatility
|
137 | % | 111 | % | ||||
Expected
dividend yield
|
- | - | ||||||
Risk
free interest rate
|
0.2 | % | 0.3 | % |
Warrants
|
||||
Outstanding
at December 31, 2008
|
3,284,000 | |||
Cancelled
|
(25,000 | ) | ||
Outstanding
at March 31, 2009
|
3,259,000 |
Warrants Issued in Connection
with:
|
Number of
Shares
|
Number of
Shares Vested
|
Exercise
Price
|
Issuance
Date
|
Expiration
Date
|
|||||||||
Series
A Stock
|
186,500 | 186,500 | $ | 1.00 |
3/15/05
|
3/15/10
|
||||||||
Series
A Stock
|
932,500 | 932,500 | 2.00 |
3/15/05
|
3/15/10
|
|||||||||
Series
B Stock
|
675,000 | 675,000 | 1.50 |
8/7/06
|
8/7/09
|
|||||||||
Consulting
agreement
|
90,000 | 90,000 | 0.65 |
1/1/07
|
1/1/10
|
|||||||||
Notes
payable financing (Note 10)
|
650,000 | 650,000 | 0.60 |
9/26/07
|
9/26/12
|
|||||||||
Consulting
agreement
|
110,000 | 110,000 | 0.65 |
1/1/08
|
1/1/11
|
|||||||||
Consulting
agreement
|
615,000 | 615,000 | 0.60 |
11/6/08
|
11/6/11
|
|||||||||
3,259,000 | 3,259,000 |
Description
|
Balance Sheet Presentation
|
Fair Value (1)
|
||||
Warrant liability for puttable warrants
|
Fair value of warrant liability
|
$ | 350 | |||
Derivative liabilities
|
Liability under derivative contracts
|
8 | ||||
$ | 358 |
Fair Value of
Warrant
Liability
|
Liability
under
Derivative
Contracts
|
Total
|
||||||||||
Balance
at December 31, 2008
|
$ | 350 | $ | 9 | $ | 359 | ||||||
Unrealized
gain included in Net loss
|
- | (1 | ) | (1 | ) | |||||||
Balance
at March 31, 2009
|
$ | 350 | $ | 8 | $ | 358 |
Year Ending
March 31,
|
Future
Minimum
Lease
Payments
|
|||
2009
|
$ | 219 | ||
2010
|
55 | |||
Total
|
$ | 274 |
Three Months Ended
March 31,
|
||||||||
2009
|
2008
|
|||||||
U.S.
|
$ | 1,711 | $ | 2,351 | ||||
Europe
and other
|
304 | 187 | ||||||
$ | 2,015 | $ | 2,538 |
March 31,
2009
|
December 31,
2008
|
|||||||
U.S.
|
$ | 2,793 | $ | 3,093 | ||||
Asia
|
50 | 59 | ||||||
Europe
|
191 | 169 | ||||||
$ | 3,034 | $ | 3,321 |
·
|
Overview.
This section provides a general description of the Company's business, as
well as recent developments that we believe are important in understanding
the results of operations and to anticipate future trends in those
operations.
|
·
|
Critical
accounting policies. This section provides an analysis of the
significant estimates and judgments that affect the reported amounts of
assets, liabilities, revenues and expenses, and related disclosure of
contingent assets and liabilities.
|
·
|
Results of
operations. This section provides an analysis of our results of
operations for the three months ended March 31, 2009 compared to the three
months ended March 31, 2008. A brief description of certain
aspects, transactions and events is provided, including related-party
transactions that impact the comparability of the results being
analyzed.
|
·
|
Liquidity
and capital resources. This section provides an analysis of our
financial condition and cash flows as of and for the three months ended
March 31, 2009 as compared to the three months ended March 31,
2008.
|
Three Months
Ended March 31,
|
||||||||||||||||
2009
|
2008
|
$ Change
|
% Change
|
|||||||||||||
Net
sales
|
$ | 2,015 | $ | 2,538 | $ | (523 | ) | (21 | )% | |||||||
Cost
of sales
|
1,237 | 1,805 | (568 | ) | (31 | ) | ||||||||||
As
a percentage of sales
|
61 | % | 71 | % | ||||||||||||
Selling,
general and administrative expense
|
1,189 | 961 | 228 | 24 | ||||||||||||
Research
and development expense
|
231 | 203 | 28 | 14 | ||||||||||||
Total
other income (expense)
|
- | (47 | ) |
NM
|
NM
|
|||||||||||
Dividend
and deemed dividend on 5% convertible preferred stock and accretion of
preferred stock redemption value
|
(12 | ) | (333 | ) |
NM
|
NM
|
|
·
|
A
higher proportion of overall net sales were generated from our more
feature-rich products, which typically bear higher gross margins than our
scanners with fewer product
features;
|
|
·
|
The
negotiated price reduction of some of our finished
product;
|
|
·
|
The
price reduction of certain third-party software as we move toward less
costly value-add software; and
|
|
·
|
Our
continued efforts toward reducing the cost of our
products.
|
·
|
Increased
stock-based compensation costs (a non-cash charge) to $147,000 during the
three months ended March 31, 2009 from $86,000 during three months ended
March 31, 2008. See “Note 6: Employee Equity Incentive
Plans” in Part I, Item 1 of this Form
10-Q.
|
·
|
Increased
investor relations efforts associated with DCT’s initiatives toward
increasing DCT’s awareness in the investment
community.
|
·
|
Increased
amortization of the fair value (a non-cash charge) of equity instruments
issued for investor relations consulting services to $111,000 during the
three months ended March 31, 2009 from $34,000 during the three months
ended March 31, 2008. See “Note 8: Equity” in Part I,
Item 1 of this Form 10-Q.
|
·
|
Increased
legal fees associated with enforcing DCT’s
patents.
|
Less Than
|
One – Three
|
Three – Five
|
||||||||||||||
Total
|
One Year
|
Years
|
Years
|
|||||||||||||
Long-term
bank line of credit (1)
|
$ | 349 | $ | 349 | $ | - | $ | - | ||||||||
Series
B Stock principal(2)
|
150 | 150 | - | - | ||||||||||||
Operating
lease obligations
|
274 | 219 | 55 | - | ||||||||||||
Consulting
agreement
|
10 | 10 | - | - | ||||||||||||
Total
contractual cash obligations
|
$ | 783 | $ | 728 | $ | 55 | $ | - |
Exhibit
Number
|
Description of Exhibit
|
Method of Filing
|
||
31.1
|
Certification
Pursuant to Section 302 of the Sarbanes-Oxley Act – David P.
Clark
|
Filed
herewith
|
||
31.2
|
Certification
Pursuant to Section 302 of the Sarbanes-Oxley Act – M. Carolyn
Ellis
|
Filed
herewith
|
||
32.1
|
Certifications
Pursuant to Section 906 of the Sarbanes-Oxley Act – David P.
Clark
|
Filed
herewith
|
||
32.2
|
Certifications
Pursuant to Section 906 of the Sarbanes-Oxley Act – M. Carolyn
Ellis
|
Filed
herewith
|
Document
Capture Technologies, Inc.
|
||
Date: May 15,
2009
|
||
/s/ David P.
Clark
|
||
David
P. Clark, Chief Executive Officer
|
||
Date:
May 15, 2009
|
||
/s/ M.
Carolyn Ellis
|
||
M.
Carolyn Ellis
|
||
Chief
Financial Officer
|